Ka lāʻau "Atokor": manual, mea like a me ka hōʻike manaʻo

High naʻokoko pae i loko o ka wai koko ka poʻea pau i ka ulu ana o ka atherosclerosis a me ka naau mai kaʻina.

No ka lawe ana lipid hakumakuma lapaʻau hoʻohana kūikawā mea, kekahi o i o ka lāʻau "Atokor". Na Ke Kumu ma keia lapaau wehewehe kona hypocholesterolemic a gipotriglitseridemicheskuyu kūlana i ka hoemi i ka lehulehu o nā palapala naʻokoko a me nā bipi kūpaluʻia i loko o ke kanaka kino.

General ano

Ka lapaau pili i nā mea kūpale o 3-methylglutaryl-3-hydroxy-CoA reductase. "Dr. Reddy mau keʻena hoʻokolohua" ua hua mai la ma ka Mauna poe.

No ka hoʻomäkaukau ' "Atokor" laʻau heluna paha e 0,020 a me ka 0,010 g.

hookuu palapala

Hua mai la hope paha ma ka papa palapala kapa komo iā ia me ke keʻokeʻo Auana. Papa extruded i loko o ka triangle shape me ka biconvex surfaces ma luna o kekahi o i ka palapala "A" Ua noi ia, a me ka mea 'ē aʻe ua koho ia e like me ka mahele lāʻau o ka "10" a me "20".

'ole

Kaʻeleu 'Oponopono o ka lāʻau ka atorvastatin, i ua poe e micronized kalipuna trihydrate. I ka lapaau "Atokor" laʻau heluna a me ka haku mele 'ana o laupaʻiʻeleu' Oponopono ikiʻokoʻa. O kela 0,01084 a 0,02168 g. O ka atorvastatin kalipuna trihydrate like paha ia 0,01 a 0,02 g. O ka maemae atorvastatin.

Waiu kōpaʻa, paʻapuna, croscarmellose paʻakai, polysorbate 80, hydroxypropyl kelulose, lactose DT, makanekiuma stearate ka papa i hana 'ole.

I ka pōkā pū ho film i hana mai hypromellose 15 cps, propylene glycol, maloko talc, titanium'okikene lua.

ʻO ia no nā mahele lāʻau o ia hoʻi, "Atokor" haku mele 'ana, a ua alakai hoi i ko lakou mau huina.

O na papa io o ka 0,01 a 0,02 g. O 10 apana i ua hanaʻia i loko o ka blister pūʻolo helu i loko o ka pepa pahu.

ʻano papa hana o ka hana

Ka lapaʻauʻia ke aʻoʻana ma o ka noi pili i ka mea e wae, nâ retarders 3-methylglutaryl-3-hydroxy-kofermentaA reductase. He nui ka'ūhū no ka huli ana o ka hui 3-hydroxy-3-metilglyutarilkoenzima A e mevalonicʻakika a ma mua o styrenes a me ka naʻokoko.

Inā hoʻomanawanui iki mai o ka hypercholesterolemia, homozygous heterozygousʻohana a me ka 'ole-ʻohana type, a hui pū dyslipidemia, ka lāʻauʻai ana "Atokor" kōkua ho'ēmi i huina naʻokoko, naʻokoko (particles) i loko o ka lipoproteins o haʻahaʻa a me ka loa haahaa nuʻa, triglycerides a me apolipoprotein B.

Medicament "Atokor" ano o ka lāʻau i ka 'kekahi ikehu no lolelua ka papa pono e hoomahuahua i ke kiʻekiʻe o ka sterol ma lipoproteins me kiʻekiʻe nuʻa.

I ake keena, a me triglycerides holesterolovye nā lātoma lilo i integral hapa o ka lipoprotein waiwai ka ikaika haʻahaʻa nuʻa. Ka mea, e hoouna aku ai i ka wai koko, i komo i loko o kaʻike ākea'aʻaʻa. O kēia mau hui i hana lipoprotein me ka haahaa saturation hiki catalyzed naoh me kiʻekiʻeʻo Solomona mea loaʻa type me ka ho okumu. A pau o kēia mau waiwai ke ka hōʻoi 'i ka hooulu ana o atherosclerotic maʻi.

Hana Atorvastatin ua wehewehe aku ma ka na hiohiona a me ka paakiki ulu i loko o ka ka hoʻokōʻana o ka LDL-mea loaʻa pono, hoemi nā palapala naʻokoko nā hoʻohui like ma ke kiekie hypercholesterolemia o homozygous hereditary type.

O ia hoʻi, "Atokor" aʻo Hōʻike kona hiki ana i lalo, wai koko naʻokoko pae a me ka lipoprotein ma ka inhibiting HMG-CoA reductase'ūhū. Ka mea, 'aʻole hoʻi ia i ke kahua o ka naʻokoko ma ke akepaʻa keena, maoli i ka helu o ka mea loaʻa ka ho okumu ana o lipoproteins me ka haʻahaʻa saturation i loko o ka halepaahao membranes. Kēia hoʻokāʻoi aʻe ana i ka hopu a me ka catabolism o ka naʻokoko, mai ka lipoprotein nā lātoma o haʻahaʻa lehulehu.

He aha ka mea i hoʻohana 'ia

Medicament "Atokor" hoʻohana Noi hoi, a kuka lawe papa ma iniiaiie na hoailona o ka mahuahua cholesterolemia heterozygous type, kūloko a me ka 'ole-kūloko ulu naʻokoko lehulehu, i hui geterlipidemii, mahuahua nui o ka wai koko triglyceride nā lātoma.

Ka mea, e lawelawe i loko o ka hui pu ana me ka dietary aʻo no ka hakumakuma kiʻekiʻe naʻokoko pae ma na lipoproteins me ka haʻahaʻa saturation, apolipoprotein B a me ka triglyceride i huiʻia.

Papa emi ka wai koko lehulehu o ka naʻokoko ma ka LDL cholesterolemia ma ke kiekie homozygousʻohana type, i ka wa a ka dietaryʻai a me nā 'ole-pharmacological ano ineffective.

Pehea e lawe

Medicament "Atokor" kauoha no ka hoʻohana i ke heluhelu inu ma hope o ka hookohu ana o ka hae hypocholesterolemicʻai maʻi kanaka, a e e hoʻohana i Inc wale. Dosing ua waiho kaawale no kēlā me kēia hoomanawanui, a he pōpilikia ma luna o ka loiloi mua kiʻekiʻe o ka naʻokoko ma lipoproteins me ka haʻahaʻa saturation. He nui ke lawe i loko, no ka Manao iho la ia hana, me ka laulā o ka Inc me "Atokor 'hoike.

Nō kāu, i ka loiloi mua laʻau heluna mea like paha 0.010 g. I kekahi manawa no ka lā. Ka hoʻohanaʻana i papa mea,ʻaʻole e kaukaʻi ma ka manawa o ka lā a me ka ai hokii.

Ke laʻau heluna o ka kela la i keia mea o ka 0,010 a hiki i 0,080 g. Ua wae mai o ka loiloi mua helu mahina nā hoailona o nā palapala naʻokoko, i ka pale umauma hoʻokahi pā a me ka laulā. Ma ka loiloi mua pae o ka palapala noi, a ma ka hoʻoulu i ka lehulehu o ka lāʻau e e hapalua o ka mahina e kaha i ka nui o ka wai koko momona, a hoʻomaʻa i ka mahele lāʻau like kupono.

Helu hypercholesterolemia a hui hyperlipidemia ano lapaau ana i kela la laʻau heluna i ka 0,010 g.

Pākōlea ha awina ia lŘlŘ i loko o 14 mau lā, a me ka mea i kā mākou ka hoʻokōʻana mea hiki ma hope o kekahi mahina. Hooloihi ae i hoʻohanaʻo ia ka mea e hiki ai ke malama i pākōlea hopena.

Lapaʻauʻia "Atokor" ma Lūkini Manual he 'ike ma terapiigiperholesterinemii o homozygousʻohana type. Nō kāu, i hoakaka ia i kela la laʻau heluna i loko o 0.080 g. Ma keia hoʻohana mea he emi ma ka LDL naʻokoko Hawaiʻi mai i ka 40%.

Hiʻona o ka lapaʻau

Nā papa "Atokor 'kauoha no ka hoʻohana ua ikaika paipaiʻia ma mua e hoʻomaka ana i ka hoʻohana' ana i ka lāʻau 'pono loaʻa i ke kumu o ka haumāna mahuahua o ka naʻokoko loina. Mau kumumea nā mimikō, ilihune lapaʻau o mimikō, hypothyroidism, nephrotic kaʻina disproteinemicheskih loli, obstructive ake maʻi. Ua hiki ke komo hou lapaʻau me nā ai 'a me ka lama. Wale ma hope o noho pakele o ka luna kumu, oe i makaukau e hoʻohana papa "Atokor".

E like ma mua Inc ua hana paa o ka lipid kaulike ma waena o ka huina naʻokoko, LDL naʻokoko i loko o ka HDL naʻokoko, a triglycerides.

'Aʻoheʻikepili ma o ka hoʻohana' ana i laau lapaau i loko o ka pediatric heluna kanaka, pela no ka mea,ʻaʻole i hōʻike kēia mau papa no nā keiki.

Ma ka iapaau ana o ka poʻeʻelemākule nā mea maʻi, o kona mau makahiki, ua oi aku mamua o 60 makahiki, o ka hoomahuahua i ka wai koko pae o ka hana Agena ke keʻena i 40%.

I Ina o ka 'aʻe' ana iʻaʻa puʻuwai functioning mea,ʻaʻole e pono e hoʻomaʻa i ka mahele lāʻau, e like me keia ano, aole ia e pili i ka atorvastatinovoe ka maʻiʻo ma ke koko, a me ka laulā o ka hookuu ino naʻokoko.

Aia ka hōʻike i ka hana ana i keia ano o ka ai 'i ka hooulu ana rabdomioliznoy myopathy a me ka lawa hakuʻala hana i loko o ka huʻi palapala. Ma kēia mau maʻi ma ka lapaʻauʻia E e kāpaeʻia i ka manawa.

Hoomakaukau i ke kumu o ka atorvastatin E e laweia'ku ke akahele i ka kanaka e hana mai ia ka waiʻona a ua i ake maʻi i loko o ka hala.

I ka hana o nā mea kūpale o HMG-CoA reductase'ūhū i e loli ma biochemical nā hoailona o ke akepaʻa kuleana pili i. No ka 'eleu mea hoʻonoho o ia' aʻe 'Pono e hoʻomaka ka loiloi' ana i hepatic haʻawina, a laila, 3 mahina ma hope o ka lawe i ka huaale lawe mai i ka loaʻa, e kaha mamua i ka lapaau.

Uluwehi O "Atokor" ma Lūkini aʻo mai nā 'ike e pili ana i na hiohiona mahuahua ma ka wai koko aiee o ka hana' Oponopono i loko o nā mea maʻi i ake maʻi, ka mea i hana eha iaʻi mai ka alcoholism. ? Aiaiiuie a piha ole o ka Inc huli akepaʻa transaminase hanana hulina i loko o ka palapala maoli. He nui nā mea maʻi i ole hoopau i ka hana o ka lāʻau i loko o ka poe liilii, nā māhele, a ua kaua kipi i adverse reactions.

Ma ka iapaau ana i haha aku kaʻona, hoʻomōhala drowsiness, no laila, i ka manawa o ke noi ana o papa nā mea maʻi i hiki ole ai i ka pāʻana amo a me nā luna 'kani.

Owai la ka mea e ole hoʻohana

Ma medicament "Atokor" contraindications loaʻa ka loa pā lonoaʻili i kēlā me kēia 'Oponopono o ka medicament.

He i ole lawe i ka hihia o ka huʻi ake maʻi a me ka kiʻekiʻe ho'ā hope o ka transaminase lāʻau lapaʻau nā'ūhū ka wā o ko lakou hope, he 3 mau manawa ma luna ma mua o ka luna palena o maʻamau nā loina.

Ke k ua i hoakaka i na wahine o ka reproductive elemakule i mea ole ka hoʻohana 'ana e pono contraception. Contraindication mea he ano o ka hanau keiki ana a me ka breastfeeding.

Medicine aʻole i hana nā keiki a me nā adolescents ma lalo makahiki 18 o ka makahiki.

Aie i ka alo ana o ka waiu i loko o ka haku mele 'ana o ka papa' Atokor "kōpaʻa aʻo ma ke noi ua papa i ka hoʻohana 'o ia i loko o ka hereditary intolerance e galactose nā lātoma, me ka nele i ka lactase a me ka monakō koko-galactose malabsortsii.

analogs

Aia nō he nui helu o ai 'ma ke kulanui o atorvastatin. Naʻokoko-hakumakuma lāʻau kūlana i "Atokor" manual. Analogs mea i hiki i lalo loa i ka nui o ka ino naʻokoko i loko o ke koko.

Kekahi e like me ka lapaʻauʻia o ka laau no ka Kolewenia "Atoris", a mea he Hookah o kumukuai poe "Krka, Novo mesto." Ua ua hua mai i loko o ka palapala o ka papa me kaʻeleu 'Oponopono ka maʻiʻo o 0.010 g., 0.020 g., 0.040 g.

Ka lāʻau 'ua manaoia e hoʻopau i ka hyperlipidemic ana, ai na mea kiko'î pono e ho'ēmi i huina naʻokoko, lipoprotein naʻokoko ma i huiʻia me ka haʻahaʻa saturation, i ka nui o ka apolipoprotein a me nā lātoma o triglyceride i loko o ke koko kahawai.

Uluwehi O kanaka Farani e kanaka me ka hypercholesterolemia polygenic heterozygous homozygousʻohana type.

Me ke kōkua o "Atoris" lāʻau maoli i ka lehulehu o ka naʻokoko ma lipoproteins me kiʻekiʻe saturation.

Kekahi Slovene mea like, noonoo iho la lāʻau "Tulip," a ua i kēia manawa "Lek mea lāʻau lapaʻau Company". Aia i ekolu dosages Auana-lole komoʻuʻuku nona papa: 0,01 g., 0,02 g. A me 0,04 g.

Ka lāʻau 'Ua hōʻike no ka hoʻopau o ka iniiaiie ano o ka hypercholesterolemic, a hui hyperlipidemic ana, no ka iapaau ana o ke kiekie naʻokoko cia heterozygous a homozygous ohana type.

Like me, nā mea noʻonoʻo Indian lapaau "Astin", a ua hua mai ma ka hana "anakahi iki Labs Limited". He loaʻa i loko o nā dosages: i 0,010 g. A me 0,020 g. O ka atorvastatin.

Ka lāʻau 'ua hoakaka ia ma ka mahuahua lipid maʻiʻo, ka wā ka mea, ua i malama maikaʻi kanawai o dietary a me nā hanana.

Mauna manufacturing he medicament "Storvas" ma muli o ke kalipuna paakai o ka atorvastatin. Ua hanaʻia e "Ranbaxy keʻena hoʻokolohua Limited" i loko o ka palapala o ka papa kapa komo iā ia me ka wahi i loko o nā dosages: i 0,010 g. A me 0,020 g.

Uluwehi O "Storvas" emi ke kiʻekiʻe ka maʻiʻo o ka huina naʻokoko, LDL naʻokoko nā lātoma i loko, a me ka lehulehu o ka apolipoprotein triglyceride i huiʻia i loko o ka puke Paipala i, a me ka nonmarried heterozygousʻohana hypercholesterolemic ana, e like me malihini a hyperlipidemic maʻi.

Ka lapaʻauʻia ho'ēmi i kā ka manawa kūpono o ka myocardial infarction myocardial nani loa moku'āina o na nāʻiʻo, hahau ana a me nā loli i loko o cerebral koko. Papa 'ūlōlohi i ka Holomua o coronary atherosclerotic kulana.

'Amelika counterpart o ka lāʻau "Lipitor" ua hua mai ia e "Pfizer". Ua ua hua mai i loko o ka palapala o ka papa kapa komo iā ia me ka iwi i loko o ekolu dosages: i 0.010 g., 0.020 g., 0.040 g. Ke k ua i hoʻohana 'ia, e hoʻopau i ka hypercholesterolemic Huipuia, oʻano o ke kumu.

Reviews

Medicine "Atokor" hoʻohana Noi wehewehe like hoʻi me ka kiʻekiʻe ai hopenaʻoi loa. He nui nā mea maʻi me ke kiekie wai koko nā hoʻohui like o nā palapala naʻokoko, ma hope o ka papa o ka hoʻohana 'ia' noho maikaʻi. e hoemi i ka maʻamau 'ilikai, a ho'ēmi i kā ka manawa o ka ulu atherosclerosis, a me ischemic aku ana i nā aiee o ka huina naʻokoko a me ka LDL naʻokoko.

Ka lāʻau e pili ana i ka Media me ka maikai tolerability, akā, i loko o kekahi e hoomanawanui i ka mea hiki i ke kali hou paepae, bloating,ʻeha i loko o ka abdomen, nausea, indigestion. Aia nā headaches, nee hiamoe. E ulu jerky, asthenic a me ka myalgic ano.

Ma pohihihi keia hoopii,ʻaoʻao 'ole e hoike mai ai ia myositis, myopathy, paresthesia,ʻike ākea neuropathy, pancreatitis, hepatitis, cholestatic jaundice.

Papa hiki i anorexia, ka luaʻi, hepatotoxicity hoikeana, alopecia, pruritic hoikeana o rashes, impotence, cataracts, hyper- paha hypoglycemia.